2025年,Sartorius Stedim生物技术公司从生物制药制造业需求增长中获得2025年强劲利润,提高了2026年的前景。 Sartorius Stedim Biotech posted strong 2025 profits from rising demand in biopharma manufacturing and raised its outlook for 2026.

Sartorius Stedim生物技术公司报告说,在生物制药制造业解决方案的持续需求推动下,2025年的盈利增长强劲,并重申了2026年及其后的积极前景,并列举了持续的市场势头和战略投资。 Sartorius Stedim Biotech reported strong profitable growth for 2025, driven by continued demand in biopharmaceutical manufacturing solutions, and reaffirmed its positive outlook for 2026 and beyond, citing sustained market momentum and strategic investments.